Skip to content

    Cancer Health Center

    Font Size
    A
    A
    A

    FDA OKs New Kidney Cancer Drug

    Afinitor Approved for Advanced Kidney Cancer That Progresses Despite Other Treatment
    By
    WebMD Health News
    Reviewed by Louise Chang, MD

    April 2, 2009 -- The FDA has approved a new drug called Afinitor to treat advanced renal cell carcinoma after other treatments fail. Renal cell carcinoma is the most common type of kidney cancer.

    Afinitor (everolimus) is taken orally. It's part of a class of drugs called kinase inhibitors, which interfere with cell communication to prevent tumor growth.

    The FDA approved Afinitor for advanced renal cell carcinoma patients who have already tried another kinase inhibitor -- Sutent or Nexavar.

    The FDA based its decision on a clinical trial that was discontinued when interim results showed that the growth or spread of the tumor was delayed in patients taking Afinitor.

    In that trial, half of the patients taking Afinitor also had slower worsening of their kidney cancer; their disease progressed after about five months, compared to two months in patients who didn't receive the drug.

    The most frequent side effects in the trial included inflammation in the mouth, loss of strength, diarrhea, poor appetite, fluid buildup in the extremities, shortness of breath, coughing, nausea, vomiting, rash, and fever.

    Lab tests also showed that at least half of all patients experienced anemia, low white blood cell counts, high cholesterol, high triglycerides, and high blood sugar, according to the FDA.

    Afinitor is made by the drug company Novartis.

    Today on WebMD

    Colorectal cancer cells
    New! I AM Not Cancer Facebook Group
    Lung cancer xray
    See it in pictures, plus read the facts.
     
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    Ovarian cancer illustration
    Real Cancer Perspectives
     
    Jennifer Goodman Linn self-portrait
    Blog
    what is your cancer risk
    HEALTH CHECK
     
    colorectal cancer treatment advances
    Video
    breast cancer overview slideshow
    SLIDESHOW
     
    prostate cancer overview
    SLIDESHOW
    lung cancer overview slideshow
    SLIDESHOW
     
    ovarian cancer overview slideshow
    SLIDESHOW
    Actor Michael Douglas
    Article